News
Visus Therapeutics Inc. expanded its pipeline via the acquisition of all patents and other assets of ViewPoint Therapeutics, Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback